Specialty Pharma Journal Specialty, Precision & Technology
PHOENIX, Ariz. – Nov. 7, 2016 – The Translational Genomics Research Institute (TGen) has discovered potential drug targets to reduce pain in pancreatic cancer patients. TGen researchers have found that the nerve growth factor (NGF), a neurotrophic factor, and its receptor TRKA are associated with perineural invasion (PNI), which is …
Tag Archives: TGen
November, 2016
November, 2015
-
6 November
Liquid Biopsy Promotes Precision Medicine by Tracking Patient’s Cancer
PHOENIX, Ariz. — Nov. 4, 2015 — A team of researchers, including scientists from the Translational Genomics Research Institute (TGen), has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient’s cancer evolves and responds to treatment. In a study published today in Nature Communications, Dr. Muhammed Murtaza …
June, 2015
-
12 June
Dell and TGen Extend Partnership in Precision Medicine Effort
IT provider Dell Inc. has extended its partnership with the Translational Genomics Research Institute (TGen) to assist researchers and physicians expand the reach and impact of precision medicine efforts for pediatric cancer. The companies announced their extended partnership, aimed at helping clinical researchers and physicians expand globally the reach and …
April, 2015
-
9 April
TGen Uses Personalized Medicine to Discover Genetic Source of Muscle Weakness in Children
State-of-the-art genetic technology has allowed scientists at the Translational Genomics Research Institute (TGen) to discover the likely cause of a child’s rare type of severe muscle weakness. The child was one of six cases that TGen sequenced, or decoded, the genes of patients with Neuromuscular Disease (NMD) and was then …